Student's use of illicit drugs: A survey in a preventive health service;Consommations de substances illicites chez les étudiants: Une enquête en service de médecine préventive

Encephale

Volumn 35, Issue SUPPL. 6, 2009, Pages

  Morvan, Y ^a,b   Rouvier, J ^a   Olie J P ^a,b   Loo H ^a,b   Krebs, M O ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Cannabis; Educational interventions; Psychotomimetic; Students; Use of substance

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; ILLICIT DRUG; PSILOCYBINE;

AMNESIA; ANXIETY; AUDITORY HALLUCINATION; BALANCE DISORDER; COORDINATION DISORDER; DEPERSONALIZATION; DRUG USE; EUPHORIA; EXPERIENCE; EXPERIMENTATION; LIFE; MENTAL CONCENTRATION; MUSHROOM; PERSONALITY; POPULATION; PREVALENCE; PREVENTIVE HEALTH SERVICE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; SAMPLE; STUDENT; UNIVERSITY HOSPITAL; VISUAL HALLUCINATION;

EID: 76149101636     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-7006(09)73471-2     Document Type: Article

References (40)

1. L. Arseneault, M. Cannon, J. Witton, et al. Causal association between cannabis and psychosis : examination of the evidence Br J Psychiatry 184 2004 110 117
2. E. Barkus, and S. Lewis Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample Psychological Medicine 38 9 2008 1267 1276
3. F. Beck, S. Legleye, and S. Spilka Consommation et surconsommation de cannabis : apports et limites de l'épidémiologie Psychotropes 13 1 2007 9 31
4. F. Beck, S. Legleye, and S. Spilka Cannabis, cocaïne, ecstasy : entre expérimentation et usage régulier, in Baromètre santé 2005 2008 Inpes Paris 169-221
5. C Bonsack, Y. Montagrin, J. Favrod, et al. Une intervention motivationnelle pour les consommateurs de cannabis souffrant de psychose Encephale 33 5 2007 819 826
6. C.M. Brett, E.P. Peters, L.C. Johns, et al. Appraisals of Anomalous Experiences Interview (AANEX) : a multidimensional measure of psychological responses to anomalies associated with psychosis Br J Psychiatry Suppl 51 2007 s23 30
7. M.R. Broome, L.C. Johns, I. Valli, et al. Delusion formation and reasoning biases in those at clinical high risk for psychosis Br J Psychiatry Suppl 51 2007 s38 42
8. A. Caspi, T.E. Moffitt, M. Cannon, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene : longitudinal evidence of a gene X environment interaction Biol Psychiatry 57 10 2005 1117 1127
9. D. Collip, I. Myin-Germeys, and J. Van Os Does the concept of « sensitization » provide a plausible mechanism for the putative link between the environment and schizophrenia ? Schizophr Bull 34 2 2008 220 225
10. A. Cougnard, M. Marcelis, I. Myin-Germeys, et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis ? A psychosis proneness-persistence model Psychol Med 37 4 2007 513 527
11. D.C. D'Souza, E. Perry, L. MacDougall, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals : implications for psychosis Neuropsychopharmacology 29 8 2004 1558 1572
12. L. Dany, and T. Apostolis L'étude des représentations sociales de la drogue et du cannabis : un enjeu pour la prévention Santé publique 14 4 2002 335 344
13. P. Deniker, J.R. Boissier, D. Etevenon, et al. Étude de pharmacologie clinique du Delta-9 tétra-hydro-cannabinol chez des sujets volontaires sains avec contrôle polygraphique Thérapie 29 1974 185 200
14. A. Dervaux, F.J. Bayle, X. Laqueille, et al. Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence Schizophr Res 81 2-3 2006 151 155
15. L. Descamps, P. Schepens, and Enquête « Géné ration cannabis » : paroles d'usagers Psychotropes 13 1 2007 83 98
16. N. Desjardin, G. D'Amours, J. Poissant, et al. Avis scientifique sur les interventions efficaces en promotion de la santé mentale et en prévention des troubles mentaux Institut National de Santé Publique du Québec 2008
17. R. Freedman Cannabis, inhibitory neurons, and the progressive course of schizophrenia Am J Psychiatry 165 4 2008 416 419
18. B. Green, D.J. Kavanagh, and R.M. Young Reasons for cannabis use in men with and without psychosis Drug Alcohol Rev 23 4 2004 445 453
19. V. Guagliardo, P. Peretti Watel, J.-B. Combes, et al. Facteurs socio-démographiques et économiques associés aux usages de tabac, d'alcool et de cannabis chez des étudiants en première année d'université en région Paca, 2005-2006 BEH 6 2009 53 56
20. W. Hall The adverse health effects of cannabis use : What are they, and what are their implications for policy ? Int J Drug Policy 2009
21. C. Henquet, M. Di Forti, P. Morrison, et al. Gene-Environment Interplay Between Cannabis and Psychosis Schizophr Bull 34 6 2008 1111 1121
22. C. Henquet, A. Rosa, P. Delespaul, et al. COMT Val (158) Met moderation of cannabis-induced psychosis : a momentary assessment study of « switching on » hallucinations in the flow of daily life Acta Psychiatr Scand 2008
23. C. Hollis, M.J. Groom, D. Das, et al. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD) Schizophr Res 105 1-3 2008 216 223
24. S. Legleye, F. Beck, P. Peretti-Watel, et al. Le role du statut scolaire et professionnel dans les usages de drogues des hommes et des femmes de 18 a 25 ans Rev Epidemiol Sante Publique 56 5 2008 345 355
25. O. Mason, C.J. Morgan, S.K. Dhiman, et al. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis Psychol Med 2008 1 6
26. J. Miettunen, S. Tormanen, G.K. Murray, et al. Association of cannabis use with prodromal symptoms of psychosis in adolescence Br J Psychiatry 192 6 2008 470 471
27. T.H. Moore, S. Zammit, A. Lingford-Hughes, et al. Cannabis use and risk of psychotic or affective mental health outcomes : a systematic review Lancet 370 9584 2007 319 328
28. I. Myin-Germeys, M. Marcelis, L. Krabbendam, et al. Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk Biol Psychiatry 58 2 2005 105 110
29. M. Prince, V. Patel, S. Saxena, et al. No health without mental health Lancet 370 9590 2007 859 877
30. M. Rais, W. Cahn, N. Van Haren, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients Am J Psychiatry 165 4 2008 490 496
31. R. Room, B. Fischer, and W. Hall, et al. Cannabis Policy : Moving beyond stalemate The Global Cannabis Commission Report 2008 The Beckley Foundation Oxford
32. M. Schneider Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure Addict Biol 13 2 2008 253 263
33. D. Schofield, C. Tennant, L. Nash, et al. Reasons for cannabis use in psychosis The Australian and New Zealand Journal of Psychiatry 40 6-7 2006 570 574
34. J. Scott, G. Martin, W. Bor, et al. The prevalence and correlates of hallucinations in Australian adolescents : results from a national survey Schizophr Res 107 2-3 2009 179 185
35. J.P. Selten, and E. Cantor-Graae Hypothesis : social defeat is a risk factor for schizophrenia ? Br J Psychiatry Suppl 51 2007 s9 s12
36. L. Simmat-Durand Usages de cannabis chez des étudiants d'une université parisienne, France, 2003-2004 BEH 50 2007 422 424
37. R.S. Stephens, R.A. Roffman, S.A. Fearer, et al. The Marijuana Check-up : promoting change in ambivalent marijuana users Addiction 102 6 2007 947 957
38. J. van Os, R.J. Linscott, I. Myin-Germeys, et al. A systematic review and meta-analysis of the psychosis continuum : evidence for a psychosis proneness-persistence-impairment model of psychotic disorder Psychol Med 39 2 2009 179 195
39. D. Versmissen, I. Myin-Germeys, I. Janssen, et al. Impairment of self-monitoring : part of the endophenotypic risk for psychosis Br J Psychiatry Suppl 51 2007 s58 62
40. M. Yucel, N. Solowij, C. Respondek, et al. Regional brain abnormalities associated with long-term heavy cannabis use Arch Gen Psychiatry 65 6 2008 694 701